Used in the pharmaceutical industry as an intermediate in the synthesis of biologically active compounds, particularly kinase inhibitors. It plays a role in the development of targeted cancer therapies due to its structural features that enable selective binding to specific enzyme sites. The compound's fluorinated aromatic system and chiral hydroxypiperidine moiety contribute to enhanced metabolic stability and improved receptor affinity. Commonly employed in research settings for structure-activity relationship (SAR) studies aimed at optimizing drug candidates for improved potency and pharmacokinetic profiles.